ACON
Aclarion, Inc.NASDAQHealthcare$3.57-4.48%ClosedMarket Cap: $1.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.00
P/S
24.01
EV/EBITDA
1689966.31
DCF Value
$22,584,539.07
FCF Yield
-393944079.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
-291.3%
Operating Margin
-9312.5%
Net Margin
-9551.9%
ROE
-0.0%
ROA
-0.0%
ROIC
-0.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $18.5K | -1221.0% | $-2.0M | $-1.9M | $-2.21 | — |
| FY 2025 | $75.7K | -291.3% | $-7.1M | $-7.2M | $-13.61 | — |
| Q3 2025 | $18.9K | 23.2% | $-1.8M | $-1.7M | $-2.93 | — |
| Q2 2025 | $19.3K | 26.6% | $-1.7M | $-1.6M | $-2.75 | — |
| Q1 2025 | $19.0K | -23.6% | $-1.5M | $-2.0M | $-9.32 | — |
| Q4 2024 | $10.2K | -100.9% | $-1.8M | $-2.0M | $-1,587.94 | — |
| FY 2024 | $45.7K | -183.8% | $-5.5M | $-7.0M | $-7,480.22 | — |
| Q3 2024 | $14.4K | -48.1% | $-1.3M | $-1.4M | $-1,320.93 | — |
| Q2 2024 | $11.0K | -112.3% | $-1.1M | $-1.2M | $-1,362.81 | — |
| Q1 2024 | $10.1K | -92.6% | $-1.3M | $-2.4M | $-3,987.04 | — |
| Q4 2023 | $13.8K | -40.7% | $-1.1M | $-1.3M | $-13,865.00 | — |
| FY 2023 | $75.4K | -0.4% | $-4.9M | $-4.9M | $-79,782.00 | — |